Obesity Clinical Trial Results

Browse clinical trials for Obesity by phase, sponsor and reported results. Data from ClinicalTrials.gov.

• Ignite Pilot: Goal Setting in a Digital Weight Loss Intervention
  N/A · Stanford University · Completed · May 16, 2025
• Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects
  Phase 4 · University of Pennsylvania · Completed · Aug 3, 2026
• Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes
  N/A · The Cleveland Clinic · Completed · Aug 3, 2026
• Time Restricted Eating for Weight Loss Maintenance
  N/A · NYU Langone Health · Completed · Jul 31, 2026
• Diabetes Prevention Program Outcomes Study
  Phase 3 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Completed · Oct 24, 2017
• Effect of PDE5 Inhibition on Adipose Metabolism in Humans
  Phase 2 · Vanderbilt University Medical Center · Completed · Jul 30, 2026
• A Mobile Health Intervention to Achieve Appropriate Gestational Weight Gain in Overweight/Obese Women
  N/A · Kaiser Permanente · Completed · Apr 18, 2025
• A Sugar-Sweetened Beverage Reduction Intervention for Native American Men
  N/A · Roswell Park Cancer Institute · Completed · Jul 28, 2026
• Summer Youth Employment Programs for Health Promotion
  Early Phase 1 · University of Houston · Completed · Jul 27, 2026
• Time Restricted Eating for Weight Management
  N/A · University of Illinois at Chicago · Completed · Jul 27, 2026
• Active You: Walk, Dance, and Tone Your Abs to Reduce Your Risk of Diabetes
  N/A · Emory University · Completed · Jul 22, 2026
• A Web-Based Healthy Living Training for Promotores
  N/A · ISA Associates, Inc. · Completed · Jul 22, 2026
• A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease
  Phase 3 · Eli Lilly and Company · Completed · Jul 20, 2026
• Does What You Eat Affect Your Brain
  N/A · University of Washington · Completed · Jul 17, 2026
• A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or O
  Phase 1 · Eli Lilly and Company · Completed · Jul 17, 2026

Trials by condition

Lung CancerNon-Small Cell Lung CancerBreast CancerColorectal CancerGastric CancerLiver CancerPancreatic CancerProstate CancerOvarian CancerMelanomaLeukemiaLymphomaMultiple MyelomaGlioblastomaType 2 DiabetesObesityHypertensionHeart FailureAtrial FibrillationStrokeChronic Kidney DiseaseNASH / MASHAlzheimer’s DiseaseParkinson’s DiseaseMultiple SclerosisDepressionEpilepsyALSRheumatoid ArthritisPsoriasisAtopic DermatitisCrohn’s DiseaseUlcerative ColitisLupusAsthmaCOPD

All trials